159 related articles for article (PubMed ID: 27616591)
1. Growth charts for individuals with rhizomelic chondrodysplasia punctata.
Duker AL; Niiler T; Eldridge G; Brereton NH; Braverman NE; Bober MB
Am J Med Genet A; 2017 Jan; 173(1):108-113. PubMed ID: 27616591
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical, and molecular characterization of mild (nonclassic) rhizomelic chondrodysplasia punctata.
Fallatah W; Schouten M; Yergeau C; Di Pietro E; Engelen M; Waterham HR; Poll-The BT; Braverman N
J Inherit Metab Dis; 2021 Jul; 44(4):1021-1038. PubMed ID: 33337545
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3.
Itzkovitz B; Jiralerspong S; Nimmo G; Loscalzo M; Horovitz DD; Snowden A; Moser A; Steinberg S; Braverman N
Hum Mutat; 2012 Jan; 33(1):189-97. PubMed ID: 21990100
[TBL] [Abstract][Full Text] [Related]
4. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata.
Bams-Mengerink AM; Majoie CB; Duran M; Wanders RJ; Van Hove J; Scheurer CD; Barth PG; Poll-The BT
Neurology; 2006 Mar; 66(6):798-803; discussion 789. PubMed ID: 16567694
[TBL] [Abstract][Full Text] [Related]
5. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform.
Barøy T; Koster J; Strømme P; Ebberink MS; Misceo D; Ferdinandusse S; Holmgren A; Hughes T; Merckoll E; Westvik J; Woldseth B; Walter J; Wood N; Tvedt B; Stadskleiv K; Wanders RJ; Waterham HR; Frengen E
Hum Mol Genet; 2015 Oct; 24(20):5845-54. PubMed ID: 26220973
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata.
Luisman T; Smith T; Ritchie S; Malone KE
Orphanet J Rare Dis; 2021 Jul; 16(1):300. PubMed ID: 34229749
[TBL] [Abstract][Full Text] [Related]
7. Rhizomelic chondrodysplasia punctata and cardiac pathology.
Huffnagel IC; Clur SA; Bams-Mengerink AM; Blom NA; Wanders RJ; Waterham HR; Poll-The BT
J Med Genet; 2013 Jul; 50(7):419-24. PubMed ID: 23572185
[TBL] [Abstract][Full Text] [Related]
8. Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.
Noguchi M; Honsho M; Abe Y; Toyama R; Niwa H; Sato Y; Ghaedi K; Rahmanifar A; Shafeghati Y; Fujiki Y
J Hum Genet; 2014 Jul; 59(7):387-92. PubMed ID: 24849933
[TBL] [Abstract][Full Text] [Related]
9. Expanding the genotypic and phenotypic landscapes of rhizomelic chondrodysplasia punctata type 3 (RCDP3) with two novel families, and a review of the literature.
İli EG; Gezdirici A; Di Pietro E; Yergeau C; Braverman N
Am J Med Genet A; 2022 Nov; 188(11):3229-3235. PubMed ID: 35986576
[TBL] [Abstract][Full Text] [Related]
10. Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies.
Barth PG; Wanders RJ; Schutgens RB; Staalman CR
Am J Med Genet; 1996 Mar; 62(2):164-8. PubMed ID: 8882397
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Fallatah W; Smith T; Cui W; Jayasinghe D; Di Pietro E; Ritchie SA; Braverman N
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31862688
[TBL] [Abstract][Full Text] [Related]
12. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor.
Purdue PE; Zhang JW; Skoneczny M; Lazarow PB
Nat Genet; 1997 Apr; 15(4):381-4. PubMed ID: 9090383
[TBL] [Abstract][Full Text] [Related]
13. Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview.
Purdue PE; Skoneczny M; Yang X; Zhang JW; Lazarow PB
Neurochem Res; 1999 Apr; 24(4):581-6. PubMed ID: 10227689
[TBL] [Abstract][Full Text] [Related]
14. Lethal form of chondrodysplasia punctata with normal plasmalogen and cholesterol biosynthesis.
Kumada S; Hayashi M; Kenmochi J; Kurosawa S; Shimozawa N; Kratz LE; Kelley RI; Taki K; Okaniwa M
Am J Med Genet; 2001 Jan; 98(3):250-5. PubMed ID: 11169563
[TBL] [Abstract][Full Text] [Related]
15. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.
Motley AM; Hettema EH; Hogenhout EM; Brites P; ten Asbroek AL; Wijburg FA; Baas F; Heijmans HS; Tabak HF; Wanders RJ; Distel B
Nat Genet; 1997 Apr; 15(4):377-80. PubMed ID: 9090382
[TBL] [Abstract][Full Text] [Related]
16. Rhizomelic chrondrodysplasia punctata type 2 resulting from paternal isodisomy of chromosome 1.
Nimmo G; Monsonego S; Descartes M; Franklin J; Steinberg S; Braverman N
Am J Med Genet A; 2010 Jul; 152A(7):1812-7. PubMed ID: 20583171
[TBL] [Abstract][Full Text] [Related]
17. A new GNPAT variant of foetal rhizomelic chondrodysplasia punctata.
Cordisco A; Pelo E; Di Tommaso M; Biagiotti R
Mol Genet Genomic Med; 2021 Aug; 9(8):e1733. PubMed ID: 34110102
[TBL] [Abstract][Full Text] [Related]
18. Type 1 rhizomelic chondrodysplasia punctata with a homozygous PEX7 mutation.
Muratoğlu Şahin N; Bilici ME; Kurnaz E; Pala Akdoğan M; Ceylaner S; Aycan Z
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):889-892. PubMed ID: 28742517
[TBL] [Abstract][Full Text] [Related]
19. A Novel Variant in the AGPS Gene Causes the Rare Rhizomelic Chondrodysplasia Punctata Type 3: A Case Report.
Shawli AM; Nazer AT; Khayyat Y; Alqurashi MG; Hakami F
Cureus; 2021 Dec; 13(12):e20543. PubMed ID: 35070570
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1.
Motley AM; Brites P; Gerez L; Hogenhout E; Haasjes J; Benne R; Tabak HF; Wanders RJ; Waterham HR
Am J Hum Genet; 2002 Mar; 70(3):612-24. PubMed ID: 11781871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
